Listing #1882996 novocure.com
220
Novocure (NASDAQ: NVCR) is an oncology company pioneering a novel therapy for solid tumors called Tumor Treating Fields, or TTFields.
Category
Website Performance
| observedTimeOriginTs | 475092896586 |
| observedLargestContentfulPaintAllFramesTs | 475094328214 |
| observedNavigationStartTs | 475092896586 |
| observedTraceEndTs | 475096700716 |
| observedTotalCumulativeLayoutShift | 0 Sec |
| observedLoadTs | 475094389498 |
| observedFirstPaint | 1.01 Sec |
| observedTimeOrigin | 0 Sec |
| observedCumulativeLayoutShift | 0 Sec |
| observedSpeedIndexTs | 475094345133 |
| observedLoad | 1.49 Sec |
| maxPotentialFID | 0.04 Sec |
| cumulativeLayoutShiftMainFrame | 0 Sec |
| observedFirstMeaningfulPaint | 1.43 Sec |
| firstContentfulPaint | 0.94 Sec |
| observedCumulativeLayoutShiftMainFrame | 0 Sec |
| largestContentfulPaint | 1.64 Sec |
| observedDomContentLoadedTs | 475094018564 |
| totalCumulativeLayoutShift | 0 Sec |
| observedFirstContentfulPaintAllFrames | 1.43 Sec |
| observedLastVisualChangeTs | 475094644586 |
| interactive | 1.22 Sec |
| observedFirstVisualChangeTs | 475094211586 |
| observedFirstContentfulPaintTs | 475094328214 |
| observedLargestContentfulPaint | 1.43 Sec |
| speedIndex | 1.57 Sec |
| cumulativeLayoutShift | 0 Sec |
| observedTraceEnd | 3.8 Sec |
| totalBlockingTime | 0 Sec |
| observedSpeedIndex | 1.45 Sec |
| firstMeaningfulPaint | 1.22 Sec |
| observedDomContentLoaded | 1.12 Sec |
| observedLargestContentfulPaintAllFrames | 1.43 Sec |
| observedNavigationStart | 0 Sec |
| observedFirstVisualChange | 1.32 Sec |
| observedFirstMeaningfulPaintTs | 475094328214 |
| observedFirstPaintTs | 475093906992 |
| observedLastVisualChange | 1.75 Sec |
| observedFirstContentfulPaintAllFramesTs | 475094328214 |
| observedFirstContentfulPaint | 1.43 Sec |
| observedLargestContentfulPaintTs | 475094328214 |
